| Year |
Citation |
Score |
| 2011 |
Liraz-Zaltsman S, Alexandrovich AG, Trembovler V, Fishbein I, Yaka R, Shohami E, Biegon A. Regional sensitivity to neuroinflammation: in vivo and in vitro studies. Synapse (New York, N.Y.). 65: 634-42. PMID 21108236 DOI: 10.1002/Syn.20889 |
0.528 |
|
| 2011 |
Fishbein I, Segal M. Active cortical innervation protects striatal neurons from slow degeneration in culture. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 445-51. PMID 20963451 DOI: 10.1007/s00702-010-0505-5 |
0.772 |
|
| 2007 |
Fishbein I, Segal M. Miniature synaptic currents become neurotoxic to chronically silenced neurons. Cerebral Cortex (New York, N.Y. : 1991). 17: 1292-306. PMID 16835294 DOI: 10.1093/cercor/bhl037 |
0.755 |
|
| 2005 |
Itsykson P, Ilouz N, Turetsky T, Goldstein RS, Pera MF, Fishbein I, Segal M, Reubinoff BE. Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Molecular and Cellular Neurosciences. 30: 24-36. PMID 16081300 DOI: 10.1016/J.Mcn.2005.05.004 |
0.554 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2009 |
Schonfeld-Dado E, Fishbein I, Segal M. Degeneration of cultured cortical neurons following prolonged inactivation: molecular mechanisms. Journal of Neurochemistry. 110: 1203-13. PMID 19508430 DOI: 10.1111/J.1471-4159.2009.06204.X |
0.281 |
|
| 2014 |
Fishbein I, Kuo YM, Giasson BI, Nussbaum RL. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation. Brain : a Journal of Neurology. 137: 3235-47. PMID 25351739 DOI: 10.1093/Brain/Awu291 |
0.161 |
|
| 2013 |
Fishbein I, Forbes SP, Chorny M, Connolly JM, Adamo RF, Corrales RA, Alferiev IS, Levy RJ. Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction. Biomaterials. 34: 6938-48. PMID 23777912 DOI: 10.1016/j.biomaterials.2013.05.047 |
0.139 |
|
| 2000 |
Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V, Sosnowski S, Slomkowski S, Golomb G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Therapy. 7: 1896-905. PMID 11127577 DOI: 10.1038/sj.gt.3301318 |
0.137 |
|
| 2014 |
Tengood JE, Alferiev IS, Zhang K, Fishbein I, Levy RJ, Chorny M. Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media. Proceedings of the National Academy of Sciences of the United States of America. 111: 4245-50. PMID 24591603 DOI: 10.1073/Pnas.1324104111 |
0.133 |
|
| 2013 |
Forbes SP, Alferiev IS, Chorny M, Adamo RF, Levy RJ, Fishbein I. Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis. Atherosclerosis. 230: 23-32. PMID 23958248 DOI: 10.1016/j.atherosclerosis.2013.06.002 |
0.132 |
|
| 2015 |
Alferiev IS, Iyer R, Croucher JL, Adamo RF, Zhang K, Mangino JL, Kolla V, Fishbein I, Brodeur GM, Levy RJ, Chorny M. Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy. Biomaterials. 51: 22-9. PMID 25770994 DOI: 10.1016/j.biomaterials.2015.01.075 |
0.13 |
|
| 2009 |
Chorny M, Fishbein I, Alferiev I, Levy RJ. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Molecular Pharmaceutics. 6: 1380-7. PMID 19496618 DOI: 10.1021/mp900017m |
0.123 |
|
| 2005 |
Fishbein I, Stachelek SJ, Connolly JM, Wilensky RL, Alferiev I, Levy RJ. Site specific gene delivery in the cardiovascular system. Journal of Controlled Release : Official Journal of the Controlled Release Society. 109: 37-48. PMID 16298010 DOI: 10.1016/j.jconrel.2005.09.031 |
0.098 |
|
| 2012 |
Chorny M, Alferiev IS, Fishbein I, Tengood JE, Folchman-Wagner Z, Forbes SP, Levy RJ. Formulation and in vitro characterization of composite biodegradable magnetic nanoparticles for magnetically guided cell delivery. Pharmaceutical Research. 29: 1232-41. PMID 22274555 DOI: 10.1007/S11095-012-0675-Y |
0.098 |
|
| 2006 |
Chorny M, Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Levy RJ. Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 382-91. PMID 16807119 DOI: 10.1016/j.ymthe.2006.03.023 |
0.095 |
|
| 2002 |
Alferiev IS, Fishbein I. Activated polyurethane modified with latent thiol groups. Biomaterials. 23: 4753-8. PMID 12361613 DOI: 10.1016/S0142-9612(02)00224-7 |
0.092 |
|
| 2003 |
Burton DY, Song C, Fishbein I, Hazelwood S, Li Q, DeFelice S, Connolly JM, Perlstein I, Coulter DA, Levy RJ. The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies. Human Gene Therapy. 14: 907-22. PMID 12828861 DOI: 10.1089/104303403765701196 |
0.09 |
|
| 1998 |
Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishbein I, Schneider A, Gazit A, Perez L, Huber R, Lazarovichi G, Rabinovich L, Levitzki A, Gertz SD. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation. 97: 1960-9. PMID 9609090 |
0.086 |
|
| 2015 |
Adamo RF, Fishbein I, Zhang K, Wen J, Levy RJ, Alferiev IS, Chorny M. Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries. Journal of Controlled Release : Official Journal of the Controlled Release Society. 222: 169-175. PMID 26704936 DOI: 10.1016/j.jconrel.2015.12.025 |
0.082 |
|
| 2010 |
Chorny M, Fishbein I, Yellen BB, Alferiev IS, Bakay M, Ganta S, Adamo R, Amiji M, Friedman G, Levy RJ. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proceedings of the National Academy of Sciences of the United States of America. 107: 8346-51. PMID 20404175 DOI: 10.1073/Pnas.0909506107 |
0.082 |
|
| 2008 |
Zaltsman SL, Fishbein I, Greeneberger V, Shohami E, Biegon A. P.4.06 Regional sensitivity or resistance to neuroinflammation: in vivo and in vitro studies European Neuropsychopharmacology. 18: s89-s90. DOI: 10.1016/S0924-977X(08)70102-0 |
0.08 |
|
| 2000 |
Fishbein I, Waltenberger J, Banai S, Rabinovich L, Chorny M, Levitzki A, Gazit A, Huber R, Mayr U, Gertz SD, Golomb G. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 667-76. PMID 10712389 |
0.078 |
|
| 2010 |
Fishbein I, Chorny M, Levy RJ. Site-specific gene therapy for cardiovascular disease. Current Opinion in Drug Discovery & Development. 13: 203-13. PMID 20205054 |
0.068 |
|
| 2008 |
Polyak B, Fishbein I, Chorny M, Alferiev I, Williams D, Yellen B, Friedman G, Levy RJ. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proceedings of the National Academy of Sciences of the United States of America. 105: 698-703. PMID 18182491 DOI: 10.1073/Pnas.0708338105 |
0.068 |
|
| 2002 |
Karck M, Meliss R, Hestermann M, Mengel M, Pethig K, Levitzki A, Banai S, Golomb G, Fishbein I, Chorny M, Haverich A. Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295. Transplantation. 74: 1335-41. PMID 12451275 |
0.066 |
|
| 2006 |
Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Vohs JM, Wong GS, Felderman H, Chen IW, Choi H, Wilensky RL, Levy RJ. Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proceedings of the National Academy of Sciences of the United States of America. 103: 159-64. PMID 16371477 DOI: 10.1073/Pnas.0502945102 |
0.065 |
|
| 2002 |
Margolin L, Fishbein I, Banai S, Golomb G, Reich R, Perez LS, Gertz SD. Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade. Atherosclerosis. 163: 269-77. PMID 12052473 DOI: 10.1016/S0021-9150(02)00035-7 |
0.064 |
|
| 2002 |
Chorny M, Fishbein I, Danenberg HD, Golomb G. Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods. Journal of Controlled Release : Official Journal of the Controlled Release Society. 83: 401-14. PMID 12387948 DOI: 10.1016/S0168-3659(02)00210-9 |
0.064 |
|
| 2013 |
Chorny M, Fishbein I, Tengood JE, Adamo RF, Alferiev IS, Levy RJ. Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2198-206. PMID 23407712 DOI: 10.1096/Fj.12-224659 |
0.064 |
|
| 1997 |
Brauner R, Laks H, Drinkwater DC, Chaudhuri G, Shvarts O, Drake T, Bhuta S, Mishaly D, Fishbein I, Golomb G. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts. The Journal of Thoracic and Cardiovascular Surgery. 114: 53-63. PMID 9240294 DOI: 10.1016/S0022-5223(97)70117-X |
0.062 |
|
| 2014 |
Fishbein I, Forbes SP, Adamo RF, Chorny M, Levy RJ, Alferiev IS. Vascular gene transfer from metallic stent surfaces using adenoviral vectors tethered through hydrolysable cross-linkers. Journal of Visualized Experiments : Jove. e51653. PMID 25145470 DOI: 10.3791/51653 |
0.061 |
|
| 2001 |
Fishbein I, Chorny M, Banai S, Levitzki A, Danenberg HD, Gao J, Chen X, Moerman E, Gati I, Goldwasser V, Golomb G. Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 1434-9. PMID 11557668 |
0.055 |
|
| 2014 |
Kruklitis RJ, Fishbein I, Singhal S, Kapoor V, Levy RJ, Alferiev IS, Sterman DH. Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors. Respiration; International Review of Thoracic Diseases. 88: 406-17. PMID 25323160 DOI: 10.1159/000368164 |
0.051 |
|
| 2002 |
Danenberg HD, Fishbein I, Gao J, Mönkkönen J, Reich R, Gati I, Moerman E, Golomb G. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation. 106: 599-605. PMID 12147543 DOI: 10.1161/01.CIR.0000023532.98469.48 |
0.046 |
|
| 2008 |
Fishbein I, Alferiev I, Bakay M, Stachelek SJ, Sobolewski P, Lai M, Choi H, Chen IW, Levy RJ. Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries. Circulation. 117: 2096-103. PMID 18413497 DOI: 10.1161/Circulationaha.107.746412 |
0.042 |
|
| 2013 |
Fishbein I, Chorny M, Adamo RF, Forbes SP, Corrales RA, Alferiev IS, Levy RJ. Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents. Angiology: Open Access. 1. PMID 26225356 DOI: 10.4172/2329-9495.1000109 |
0.042 |
|
| 1962 |
FISHBEIN IL. The deeper meanings of life. The Bulletin [of] the University of Miami School of Medicine and Jackson Memorial Hospital. University of Miami. School of Medicine. 16: 17-8. PMID 13893201 |
0.041 |
|
| 1998 |
Chorny M, Fishbein I, Banai S, Levitzki A, Gertz SD, Rabinovich L, Perez L, Gazit A, Golomb G. In vitro and in vivo characteristics of tyrosine kinase inhibitor-containing PLA nanoparticles Proceedings of the Controlled Release Society. 667-668. |
0.039 |
|
| 2012 |
Chorny M, Fishbein I, Adamo RF, Forbes SP, Folchman-Wagner Z, Alferiev IS. Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis. Methodist Debakey Cardiovascular Journal. 8: 23-7. PMID 22891107 |
0.036 |
|
| 2003 |
Danenberg HD, Fishbein I, Epstein H, Waltenberger J, Moerman E, Mönkkönen J, Gao J, Gathi I, Reichi R, Golomb G. Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery. Journal of Cardiovascular Pharmacology. 42: 671-9. PMID 14576517 DOI: 10.1097/00005344-200311000-00014 |
0.035 |
|
| 1999 |
Fishbein I, Chorny M, Rabinovich L, Banai S, Gertz S, Levitzki A, Gazit A, Golomb G. Formulation factors and in vivo characterization of nanoparticles in restenosis Proceedings of the Controlled Release Society. 54-55. |
0.034 |
|
| 1997 |
Orloff LA, Domb AJ, Teomim D, Fishbein I, Golomb G. Biodegradable implant strategies for inhibition of restenosis Advanced Drug Delivery Reviews. 24: 3-9. DOI: 10.1016/S0169-409X(96)00478-4 |
0.032 |
|
| 1959 |
FISHBEIN IL. Crusade in America: the pursuit of equanimity. American Practitioner and Digest of Treatment. 10: 937-8. PMID 13650102 |
0.029 |
|
| 1999 |
Danenberg HD, Monkkonen J, Fishbein I, Gati I, Chorny M, Banai S, Waltenberger JW, Levitzky A, Gertz DS, Golomb G. Controlled release of drugs from multiparticulate delivery systems in animal models of restenosis Proceedings of the Controlled Release Society. 52-53. |
0.028 |
|
| 1995 |
Golomb G, Fishbein I, Banai S, Moscovitz D, Mishaly D, Gertz SD, Gazit A, Levitzki A. Inhibition of restenosis in a rat model by perivascular delivery of a tyrphostin compound Proceedings of the Controlled Release Society. 151-152. |
0.028 |
|
| 2009 |
Liraz-Zaltsman S, Alexandrovich A, Fishbein I, Greeneberger V, Shohami E, Biegon A. PO22-TH-13 Regional sensitivity to neuroinflammation Journal of the Neurological Sciences. 285. DOI: 10.1016/S0022-510X(09)71055-X |
0.027 |
|
| 2000 |
Fishbein I, Chorny M, Golomb G. Treatment of restenosis by controlled-release delivery systems of tyrphostins Drug Development Research. 50: 487-496. |
0.025 |
|
| 1996 |
Golomb G, Fishbein I, Banai S, Mishaly D, Moscovitz D, Gertz SD, Gazit A, Poradosu E, Levitzki A. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis. 125: 171-82. PMID 8842349 DOI: 10.1016/0021-9150(96)05868-6 |
0.024 |
|
| 1951 |
FISHBEIN IL. Psychiatric highlights of the First International Congress of Psychiatry, Paris, September 18-27, 1950. The Journal of the Florida Medical Association. Florida Medical Association. 38: 181-7. PMID 14861396 |
0.021 |
|
| 2001 |
Fishbein I, Brauner R, Chorny M, Gao J, Chen X, Laks H, Golomb G. Local delivery of mithramycin restores vascular reactivity and inhibits neointimal formation in injured arteries and vascular grafts. Journal of Controlled Release : Official Journal of the Controlled Release Society. 77: 167-81. PMID 11733085 DOI: 10.1016/S0168-3659(01)00472-2 |
0.02 |
|
| 2005 |
Banai S, Chorny M, Gertz SD, Fishbein I, Gao J, Perez L, Lazarovichi G, Gazit A, Levitzki A, Golomb G. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials. 26: 451-61. PMID 15275819 DOI: 10.1016/j.biomaterials.2004.02.040 |
0.02 |
|
| 2000 |
Fishbein I, Chorny M, Rabinovich L, Banai S, Gati I, Golomb G. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 65: 221-9. PMID 10699282 DOI: 10.1016/S0168-3659(99)00244-8 |
0.019 |
|
| 1997 |
Mishaly D, Fishbein I, Moscovitz D, Golomb G. Site-specific delivery of colchicine in rat carotid artery model of restenosis Journal of Controlled Release. 45: 65-73. DOI: 10.1016/S0168-3659(96)01546-5 |
0.016 |
|
| 1949 |
FISHBEIN IL. Involutional melancholia and convulsive therapy. The American Journal of Psychiatry. 106: 28-35. PMID 18135401 |
0.015 |
|
| 1978 |
Fishbein IL. William Harvey remembered. The Journal of the Florida Medical Association. 65: 265-7. PMID 347024 |
0.014 |
|
| 2013 |
Ma G, Wang Y, Fishbein I, Yu M, Zhang L, Alferiev IS, Yang J, Song C, Levy RJ. Anchoring of self-assembled plasmid DNA/anti-DNA antibody/cationic lipid micelles on bisphosphonate-modified stent for cardiovascular gene delivery. International Journal of Nanomedicine. 8: 1029-35. PMID 23687446 DOI: 10.2147/IJN.S40077 |
0.01 |
|
| 2011 |
Chorny M, Fishbein I, Forbes S, Alferiev I. Magnetic nanoparticles for targeted vascular delivery. Iubmb Life. 63: 613-20. PMID 21721100 DOI: 10.1002/iub.479 |
0.01 |
|
| 2009 |
Fishbein I, Levy RJ. Analytical chemistry: The matrix neutralized. Nature. 461: 890-1. PMID 19829362 DOI: 10.1038/461890a |
0.01 |
|
| 2002 |
Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 83: 389-400. PMID 12387947 DOI: 10.1016/S0168-3659(02)00211-0 |
0.01 |
|
| 2000 |
Chorny M, Fishbein I, Golomb G. Drug delivery systems for the treatment of restenosis. Critical Reviews in Therapeutic Drug Carrier Systems. 17: 249-84. PMID 10868290 |
0.01 |
|
| 1997 |
Golomb G, Fishbein I. Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis Advanced Drug Delivery Reviews. 24: 53-62. DOI: 10.1016/S0169-409X(96)00482-6 |
0.01 |
|
| 1997 |
Golomb G, Fishbein I, Moscovitz D, Gertz SD, Levitzki A, Pearle A, Perez L, Schneider A, Gazit A, Banai S. Inhibitors of protein tyrosine kinase for site specific therapy of restenosis Proceedings of the Controlled Release Society. 187-188. |
0.01 |
|
| 1996 |
Fishbein I, Banai S, Levitzki A, Moscovitz D, Gertz SD, Gazit A, Golomb G. Perivascular and intraluminal delivery systems of a tyrphostin for the treatment of restenosis Proceedings of the Controlled Release Society. 17-18. |
0.01 |
|
| 1990 |
Fishbein IL. James G. Lyerly remembered. The Journal of the Florida Medical Association. 77: 798. PMID 2230700 |
0.01 |
|
| 1976 |
Kopeika NS, Even-Zur D, Fishbein I. Low-Cost Glow Discharge Tube Microwave Frequency Sensor Proceedings of the Ieee. 64: 382-384. DOI: 10.1109/PROC.1976.10132 |
0.01 |
|
| 1975 |
Fishbein IL. Albert Schweitzer remembered. The Journal of the Florida Medical Association. 62: 13-6. PMID 1089134 |
0.01 |
|
| 1973 |
Fishbein IL. Copernicus remembered. Jfma, the Journal of the Florida Medical Association. Florida Medical Association. 60: 32-3. PMID 4569215 |
0.01 |
|
| 1964 |
FISHBEIN IL. AUTOMATION AND INDIVIDUAL RESPONSIBILITY. The Journal of the Florida Medical Association. Florida Medical Association. 51: 373-4. PMID 14158659 |
0.01 |
|
| Hide low-probability matches. |